Lixte Biotechnology Holdings Inc (LIXT)

04:35 AM

Will Lixte Biotechnology Holdings Inc. (8640) stock beat revenue estimatesFed Meeting & Low Risk Entry Point Tips - ulpravda.ru

04:35 AM

04:28 AM

How Lixte Biotechnology Holdings Inc. stock compares to growth peers2025 Biggest Moves & Technical Entry and Exit Tips - ulpravda.ru

04:28 AM

03:50 AM

LIXTE Biotechnology Holdings (LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - Yahoo Finance

03:50 AM

01:16 AM

Lixte Biotechnology Expands Ovarian Cancer Trial with MD Anderson and GSK - citybuzz -

01:16 AM

12:05 PM

Will Lixte Biotechnology Holdings Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Low Drawdown Investment Ideas - ulpravda.ru

12:05 PM

12:02 PM

How strong is Lixte Biotechnology Holdings Inc. Equity Warrant stock revenue growth2025 Trade Ideas & Entry Point Strategy Guides - ulpravda.ru

12:02 PM

11:25 AM

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - financial-news.co.uk

11:25 AM

10:57 AM

Can Lixte Biotechnology Holdings Inc. (8640) stock ride next bull market cycleJuly 2025 Retail & Free Verified High Yield Trade Plans - ulpravda.ru

10:57 AM

10:12 AM

Breakout Zone: Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Weekly Recap & Real-Time Market Sentiment Reports - ulpravda.ru

10:12 AM

Jan 07, 2026

Can Lixte Biotechnology Holdings Inc. stock continue upward trendEarnings Forecast Updates & High Yield Trading Growth - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Lixte Biotechnology Holdings (NASDAQ: LIXT) Announces $4.3M Registered Direct Offering Priced at Market - Digital Journal

Jan 07, 2026

Jan 07, 2026

LIXTE Biotechnology Advances Novel Cancer Treatment Platform Through Clinical Trials and Strategic Moves - citybuzz -

Jan 07, 2026

Jan 07, 2026

Lixte Biotechnology Holdings Secures $4.3 Million in Registered Direct Offering to Advance Cancer Drug Development - citybuzz -

Jan 07, 2026

Jan 07, 2026

About Us | Oil & Gas JournalLIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is ‘One to Watch’ - FinancialContent

Jan 07, 2026

Jan 07, 2026

About Us - FinancialContent

Jan 07, 2026

Jan 06, 2026

Will Lixte Biotechnology Holdings Inc. (8640) stock deliver compounding returns2026 world cup usa national team quarterfinals young talents transition play winner prediction breakdown - ulpravda.ru

Jan 06, 2026

Jan 06, 2026

Aug Decliners: Why Lixte Biotechnology Holdings Inc. (8640) stock is listed among top recommendationsInsider Buying & Weekly Momentum Stock Picks - moha.gov.vn

Jan 06, 2026

Jan 03, 2026

What analysts say about Lixte Biotechnology Holdings Inc 8640 stockCandlestick Trading Patterns & High Return Stock Picks - earlytimes.in

Jan 03, 2026

Jan 03, 2026

What analysts say about SBCWW stockTechnical Breakout Signals & Free Wealth Planning Blueprints - earlytimes.in

Jan 03, 2026

Jan 03, 2026

Should You Add Aster DM Healthcare Limited Stock to Your Portfolio NowResistance Breakout Alerts & Minimal Capital Growth - earlytimes.in

Jan 03, 2026

Jan 01, 2026

Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationAnalyst Upgrades & Free High Yield Investment Strategies - bollywoodhelpline.com

Jan 01, 2026

Dec 31, 2025

Lixte Simplifies Capital Structure via Share Exchange Deal - TipRanks

Dec 31, 2025

Dec 29, 2025

Price Clustering Detected in Anupam Finserv Limited StockLong-Term Investment Plans & Low Risk High Yield - bollywoodhelpline.com

Dec 29, 2025

Dec 25, 2025

Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit Strategies & Low Entry Investment Portfolio - Bollywood Helpline

Dec 25, 2025

Dec 24, 2025

LIXTE expands clinical trial for ovarian cancer treatment By Investing.com - Investing.com Australia

Dec 24, 2025

Dec 23, 2025

Lixte Expands LB-100 Ovarian Cancer Trial Collaboration - TipRanks

Dec 23, 2025

Dec 23, 2025

Lixte expands LB-100 ovarian cancer trial collaboration - MSN

Dec 23, 2025

Dec 23, 2025

Key facts: Lixte Biotechnology secures $4.3M funding; expands cancer collaboration - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

LIXTE expands clinical trial for ovarian cancer treatment - Investing.com

Dec 23, 2025

Dec 23, 2025

Lixte Biotechnology Holdings expands collaboration with University of Texas MD Anderson Cancer Center & GSK for LB-100 - marketscreener.com

Dec 23, 2025

Dec 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial - InvestorNews

Dec 23, 2025

Dec 23, 2025

Experimental ovarian cancer trial doubles the number of patients it will enroll - Stock Titan

Dec 23, 2025

Dec 22, 2025

Spartan Capital acts as placement agent in Lixte’s $4.3 million offering - Investing.com Nigeria

Dec 22, 2025

Dec 22, 2025

Lixte Biotechnology Announces New Registered Direct Offering - TipRanks

Dec 22, 2025

Dec 22, 2025

Lixte Biotechnology Signs Multiple Material Agreements - TradingView — Track All Markets

Dec 22, 2025

Dec 22, 2025

Spartan Capital acts as placement agent in Lixte’s $4.3 million offering By Investing.com - Investing.com South Africa

Dec 22, 2025

Dec 22, 2025

Lixte Biotechnology stock falls after $4.3 million direct offering - Investing.com

Dec 22, 2025

Dec 22, 2025

Lixte Biotechnology stock falls after $4.3 million direct offering By Investing.com - Investing.com Canada

Dec 22, 2025

Dec 22, 2025

Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering - The Manila Times

Dec 22, 2025

Dec 20, 2025

Will Lixte Biotechnology Holdings Inc. stock keep outperforming rivalsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда

Dec 20, 2025

Dec 20, 2025

Whale Trades: Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyMarket Growth Report & Entry and Exit Point Strategies - Улправда

Dec 20, 2025

Dec 20, 2025

Profit Recap: What sentiment indicators say about Lixte Biotechnology Holdings Inc stockJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - moha.gov.vn

Dec 20, 2025

Dec 20, 2025

Momentum Shift: Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuation2025 Analyst Calls & Fast Entry Momentum Trade Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

Can Lixte Biotechnology Holdings Inc. Equity Warrant stock deliver consistent earnings growthPortfolio Gains Report & Fast Momentum Entry Tips - Улправда

Dec 20, 2025

Dec 19, 2025

What Wall Street predicts for Lixte Biotechnology Holdings Inc. Equity Warrant stock pricePortfolio Return Report & Daily Profit Maximizing Trade Tips - Улправда

Dec 19, 2025

Dec 19, 2025

Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyTrade Risk Summary & Weekly Market Pulse Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesInsider Buying & Expert Approved Trade Ideas - Улправда

Dec 19, 2025

Dec 19, 2025

Will Lixte Biotechnology Holdings Inc. stock outperform tech sector in 2025Share Buyback & Stepwise Trade Execution Plans - Улправда

Dec 19, 2025

Dec 19, 2025

Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Lixte Biotechnology Holdings Inc. Equity Warrant stock attractive for hedge funds2025 Technical Overview & Community Verified Watchlist Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is Lixte Biotechnology Holdings Inc. (8640) stock nearing a technical breakoutQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

What dividend safety rating applies to Lixte Biotechnology Holdings Inc. (8640) stockWeekly Trend Recap & AI Forecasted Entry/Exit Points - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Lixte Biotechnology Holdings Inc. stock split again soon2025 Geopolitical Influence & Advanced Technical Signal Analysis - Улправда

Dec 19, 2025